Vira Regen Competitors and Similar CompaniesClear all
Pharmacyclics's competitors and similar companies include Exelixis.
 Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | ||
Founding Date | Founding Date 1991 | Founding Date 1994 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Sunnyvale, US HQ | Locations Alameda, US HQ |
Employees | Employees 6551% decrease | Employees 1,14712% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods $40.4m (FY, 2014) | Cost of goods $83.7m (FY, 2025) |
Gross profit | Gross profit $689.3m (FY, 2014) | Gross profit $2.2b (FY, 2025) |
Net income | Net income $86.1m (FY, 2014) | Net income $782.6m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View company